rosiglitazone has been researched along with thromboplastin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clancy, P; Golledge, J; Mangan, S | 1 |
| Cho, HJ; Choi, YE; Kim, BK; Kim, HS; Kwon, YW; Lee, HC; Lee, SW; Muller, DN; Park, JB; Park, KW; Yang, HM; Youn, SW | 1 |
| Ciaraldi, TP; Samad, F; Wang, J | 1 |
| Dai, L; Sun, Y; Wang, J; Yu, L | 1 |
1 trial(s) available for rosiglitazone and thromboplastin
| Article | Year |
|---|---|
Tissue factor expression in obese type 2 diabetic subjects and its regulation by antidiabetic agents.
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gene Expression Regulation; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Rosiglitazone; Thiazolidinediones; Thromboplastin | 2015 |
3 other study(ies) available for rosiglitazone and thromboplastin
| Article | Year |
|---|---|
Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fenofibrate; Humans; Ischemic Attack, Transient; Ligands; Lipoproteins; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR gamma; Rosiglitazone; Signal Transduction; Stroke; Thiazolidinediones; Thromboplastin | 2007 |
Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusion.
Topics: Animals; Catheterization; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Infusions, Intra-Arterial; Lipoproteins; Mitogen-Activated Protein Kinases; Models, Biological; Monocytes; Muscle, Smooth, Vascular; Paclitaxel; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Sirolimus; Thiazolidinediones; Thromboplastin; Umbilical Arteries | 2011 |
[Effects of proliferator-activated receptor-γ agonist on vascular endothelial injuries in septic rats].
Topics: Angiopoietin-2; Anilides; Animals; Endothelium, Vascular; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones; Thromboplastin; Vascular Cell Adhesion Molecule-1 | 2015 |